We are live on ! Find out more
MYGN icon

Myriad Genetics
MYGN

228 hedge funds and large institutions have $833M invested in Myriad Genetics in 2025 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 79 increasing their positions, 79 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

402% more call options, than puts

Call options by funds: $854K | Put options by funds: $170K

28% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 29

3% more funds holding

Funds holding: 221 → 228 (+7)

1.26% more ownership

Funds ownership: 101.59% → 102.85% (+1.3%)

0% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 79

34% less capital invested

Capital invested by funds: $1.27B → $833M (-$436M)

Holders
228
Holders Change
+7
Holders Change %
+3.17%
% of All Funds
3.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
37
Increased
79
Reduced
79
Closed
29
Calls
$854K
Puts
$170K
Net Calls
+$684K
Net Calls Change
-$3.13M

Top Buyers

Rank Fund Capital Flow
1
DGI
Disciplined Growth Investors
Minnesota
+$26.1M
2
Balyasny Asset Management
Balyasny Asset Management
Illinois
+$9.36M
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$8.44M
4
PCM
Portolan Capital Management
Massachusetts
+$6.6M
5
Voloridge Investment Management
Voloridge Investment Management
Florida
+$5.08M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$17M
2
CCM
Camber Capital Management
Massachusetts
-$9.01M
3
Artisan Partners
Artisan Partners
Wisconsin
-$5.88M
4
Pictet Asset Management
Pictet Asset Management
Switzerland
-$5.6M
5
BlackRock
BlackRock
New York
-$5.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
201
Parallel Advisors
California
$1.29K +$288 +24 +20%
MPWT
202
MassMutual Private Wealth & Trust
Connecticut
$1.26K +$673 +56 +65%
LFG
203
Larson Financial Group
Missouri
$1.26K +$1.55K +129 +992%
PFBT
204
Parkside Financial Bank & Trust
Missouri
$1.15K +$396 +33 +34%
PWAM
205
Private Wealth Asset Management
Iowa
$1.03K +$1.39K +116 New
SS
206
SBI Securities
Japan
$1K +$108 +9 +9%
C
207
Covestor
United Kingdom
$1K +$456 +38 +84%
RIL
208
Rothschild Investment LLC
Illinois
$931 +$901 +75 +250%
CIAS
209
CBIZ Investment Advisory Services
Ohio
$887 – – –
BFS
210
Bare Financial Services
Pennsylvania
$843 +$1.14K +95 New
FFA
211
Farther Finance Advisors
California
$751 -$324 -27 -24%
HFM
212
Hartford Financial Management
Connecticut
$533 – – –
FMII
213
Farmers & Merchants Investments Inc
Nebraska
$532 – – –
SPIA
214
Steward Partners Investment Advisory
New York
$514 – – –
Barrow, Hanley, Mewhinney & Strauss
215
Barrow, Hanley, Mewhinney & Strauss
Texas
$497 +$673 +56 New
BAM
216
Byrne Asset Management
New Jersey
$444 – – –
SC
217
Stephens Consulting
Michigan
$355 +$480 +40 New
FHA
218
First Horizon Advisors
Tennessee
$337 – – –
TSMHT
219
Thurston Springer Miller Herd & Titak
Indiana
$266 +$360 +30 New
HNB
220
Huntington National Bank
Ohio
$248 +$336 +28 New
RI
221
Ridgewood Investments
New Jersey
$207 -$12 -1 -4%
SIS
222
Sound Income Strategies
Florida
$195 – – –
SW
223
SVB Wealth
Massachusetts
$89 +$120 +10 New
TC
224
Truvestments Capital
Florida
$89 +$120 +10 New
AWM
225
Abound Wealth Management
Tennessee
$63 – – –
7 8
9
10 11

MYGN Hedge Fund Activity: Q1 2025 in Review

228 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Myriad Genetics (MYGN) for Q1 2025, worth a combined $833M — down 34% from $1.27B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new MYGN positions and 29 closed out — a net gain of 8 holders — while 79 added to existing stakes and 79 trimmed.

The largest buyer was Disciplined Growth Investors, adding an estimated $26.1M. The largest seller was Wellington Management Group, cutting an estimated $17M.

  • 228 institutional investors held Myriad Genetics (MYGN) as of Q1 2025, up from 221 in Q4 2024.
  • Funds reported $833M of Myriad Genetics stock for Q1 2025, down 34% quarter-over-quarter.
  • 37 funds opened new Myriad Genetics positions in Q1 2025 and 29 closed out, a net change of +8 holders.
  • The largest Myriad Genetics buyer in Q1 2025 was Disciplined Growth Investors, an estimated $26.1M added.
  • The largest Myriad Genetics seller in Q1 2025 was Wellington Management Group, an estimated $17M sold.

Based on aggregated 13F filings for Q1 2025.